Avatar-Based Decision Support Technology for Surrogate Decision Makers
针对代理决策者的基于阿凡达的决策支持技术
基本信息
- 批准号:8433655
- 负责人:
- 金额:$ 47.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdmission activityAdvance Care PlanningAdvocateAgingAmericanAnxietyAreaCaringChronic CareComplexConflict (Psychology)DataDecision AidDecision MakingDecision Support SystemsDeteriorationDevelopmentDistressElderlyElectronicsElementsEvaluationFaceFamily memberFrequenciesFriendsFutureGoalsHealthHealth StatusHealth TechnologyHealthcareHospitalizationHospitalsImpaired cognitionIndividualInterventionInvestigationKnowledgeMedicalMental DepressionNatureNursing HomesOutcomePatient PreferencesPatientsPersonsPhasePopulationPreparationProbabilityQuality of lifeRandomized Clinical TrialsReadinessRegretsRelative (related person)ResearchResourcesResuscitationRiskRoleSelf EfficacySignal TransductionSkilled Nursing FacilitiesStressSystemTaxesTechnologyTestingTimeTrainingUncertaintyVisitarmbaseclinical practicedesignexperiencefunctional statusloved onesnovelpreferenceprogramspsychological distresspublic health relevancesatisfactionsimulationsurrogate decision makertreatment as usualtrial comparing
项目摘要
DESCRIPTION (provided by applicant): One of the most burdensome responsibilities faced by any family member is making health care decisions for a loved one who is decisionally impaired. Given the aging of the population and increasing options for treatment of acute illnesses, most Americans will find themselves facing this tremendous challenge of assuming the surrogate decision maker role for a relative or friend. Despite the frequency with which family members face this taxing responsibility, we have yet to identify effective ways to support them in decision making. This project builds on an established decision support framework and the team's prior experience with health technology. We aim to create an interactive, avatar-based, tailored intervention using serious gaming technology to deliver decision support to surrogate decision makers in preparation for post-discharge decisions about a patient's resuscitation and rehospitalization status. The purpose of this study is the development and evaluation of a novel decision support strategy that, if shown to be effective, can be widely disseminated and offered to surrogate decision makers facing the many significant health care decisions required in the acute and chronic care of their cognitively impaired loved one. The project is planned in two phases: Phase 1 will consist of the creation, development, and design of an interactive, avatar-based, individually tailored electronic program that will engage and prepare family members for the role of surrogate decision maker. Phase 2 will be a three-arm, randomized, clinical trial comparing the tailored, avatar-based simulation system, "electronic Surrogate Decision Maker Resources and Tailored Training" (eSMARTT) with a non-tailored passive educational program, "electronic Nursing Home Decision Aid" (eNHDA), and with usual care (UC). By engaging surrogate decision makers as co-designers and evaluators of decision support strategies, this application will generate data that will have a significant impact on clinical practice and the future direction of research in this area.
描述(由申请人提供):任何家庭成员面临的最繁重的责任之一是为决策受损的亲人做出医疗保健决定。鉴于人口老龄化和急性疾病治疗的选择越来越多,大多数美国人将发现自己面临着为亲戚或朋友承担代理决策者角色的巨大挑战。尽管家庭成员经常面临这种纳税责任,但我们尚未找到有效的方法来支持他们做出决策。该项目建立在一个既定的决策支持框架和该小组先前在卫生技术方面的经验基础上。我们的目标是创建一个互动的,基于化身的,定制的干预使用严重的游戏技术,提供决策支持,以代理决策者准备出院后的决定,病人的复苏和再住院状态。本研究的目的是开发和评估一种新的决策支持策略,如果被证明是有效的,可以广泛传播,并提供给代理决策者面临的许多重大的医疗保健决策所需的急性和慢性护理的认知受损的亲人。该项目计划分为两个阶段:第一阶段将包括创建,开发和设计一个互动的,基于化身的,个性化定制的电子程序,该程序将使家庭成员参与并准备代理决策者的角色。第二阶段将是一项三臂、随机、临床试验,比较定制的、基于化身的模拟系统、“电子代孕决策者资源和定制培训”(eSMARTT)与非定制的被动教育计划、“电子护理之家决策辅助”(eNHDA)和常规护理(UC)。通过让代理决策者作为决策支持策略的共同设计者和评估者,该应用程序将生成对临床实践和该领域未来研究方向产生重大影响的数据。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald Lee Hickman其他文献
Ronald Lee Hickman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald Lee Hickman', 18)}}的其他基金
Clinical and Translational Science Collaborative of Northern Ohio, An Intensive Summer Education Program in Translational Research for Underrepresented Students (INSPIRE-US)
俄亥俄州北部的临床和转化科学合作组织,针对代表性不足的学生的转化研究强化暑期教育项目 (INSPIRE-US)
- 批准号:
10703730 - 财政年份:2023
- 资助金额:
$ 47.55万 - 项目类别:
A Clinical Trial of Decision Support for End of Life Care Among Surrogate Decision Makers of the Chronically Critically Ill
慢性危重病替代决策者临终关怀决策支持的临床试验
- 批准号:
9281558 - 财政年份:2015
- 资助金额:
$ 47.55万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 47.55万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 47.55万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 47.55万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 47.55万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 47.55万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 47.55万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 47.55万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 47.55万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 47.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 47.55万 - 项目类别:
Operating Grants














{{item.name}}会员




